Up Over 10% This Year, How High Can Cineplex Stock Rally?

With Cineplex stock seeing an improvement in box office numbers and on the verge of profitability, here’s how high it could rally in 2023.

| More on:
A stock price graph showing growth over time

Image source: Getty Images.

After Cineplex (TSX:CGX) stock struggled throughout the pandemic, and after falling by more than 40% through 2022, it finally looks like 2023 will be the year it can turn its business around.

So far, already year to date, the stock is up by more than 10%. Furthermore, Cineplex stock is up 17% since mid-March, when it reported its strong box office numbers for February.

One of the biggest obstacles it has faced in the last few months is that even without capacity restrictions, a lack of compelling content as Hollywood plays catch-up from its pandemic shutdowns has hindered Cineplex stock from recovering sooner.

However, the box office numbers are now showing that as more blockbuster films get released, Cineplex has the potential to see a significant recovery in profitability this year, which could lead to a major rally.

In both January and February this year, box office numbers were roughly 88% of 2019 levels, representing a strong start to 2023. Furthermore, as the year goes on, more movies are set to be released.

By my count, there are more than 20 blockbuster movies scheduled to be released this year, including five superhero movies, several sequels of popular films, as well as highly anticipated movies such as Barbie.

Therefore, not only are pandemic restrictions not impacting Cineplex anymore, but Hollywood has also now clearly recovered from production shutdowns.

And as that leads to a recovery in attendance, it should have a significant influence on Cineplex’s ability to see its revenue recover and, most importantly, start becoming profitable again.

With Cineplex stock on the verge of profitability, it could rally significantly in 2023

As I mentioned above, 2022 saw many pandemic restrictions lifted, which led to a nearly 100% year-over-year increase in Cineplex stock’s revenue to just shy of $1.3 billion. Furthermore, it lost just $0.10 per share in 2022, compared to a loss of $4.46 per share in 2021 and $5.83 in 2020.

Plus, for 2023, analysts expect that not only will its revenue continue to rebound, to roughly $1.6 billion, but Cineplex should be able to generate earnings per share (EPS) of $0.50.

Therefore, the stock clearly has the potential for a consistent rally, especially when you consider how cheap it trades today.

How cheap is Cineplex today?

With the stock trading at less than $9 a share today, Cineplex has a forward price-to-earnings (P/E) ratio of less than 18 times. Furthermore, it’s trading at less than 8.9 times its expected 2024 earnings.

That’s not just undervalued; it’s also well below where Cineplex stock traded prior to the pandemic. For example, in 2019, it had an average P/E ratio of 26.4 times earnings.

Therefore, as long as there aren’t any unforeseen roadblocks that impact Cineplex’s operations throughout 2023, it has the potential to rally significantly.

To get to a P/E ratio of more than 26 times, Cineplex stock would have to rally to around $13 a share, roughly 45% higher than where it trades today. And it’s worth pointing out that right now, the average analyst target price is $12.76, shy of $13.

Furthermore, if Cineplex can see a noticeable improvement in its profitability and continue recovering through 2023, it could even rally past $13, considering that analysts expect it will earn $1.00 in EPS next year.

Therefore, by the end of 2023, even if Cineplex still only had a forward P/E ratio of 18 times as it does today, as long as analyst estimates remain the same, the stock could rally to roughly $18 a share, more than 100% higher than where it trades right now.

So if you have cash that you’re looking to invest and want to buy a high-potential stock that’s trading ultra-cheap, Cineplex is certainly one of the best companies to keep your eye on over the next few months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned. The Motley Fool recommends Cineplex. The Motley Fool has a disclosure policy.

More on Investing

A worker overlooks an oil refinery plant.
Energy Stocks

The Ultimate Energy Stock to Buy With $500 Right Now

Do you want to invest in the ultimate energy stock but only have $500? Here's one stock that can set…

Read more »

Young woman sat at laptop by a window
Dividend Stocks

5% Dividend Yield: Why I Will Be Buying and Holding This TSX Stock for Decades!

Stability and a healthy return potential are among the hallmarks of the so-called “forever stocks.” But while many stocks promise…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Stocks for Beginners

Maximize Your $7,000 TFSA Limit in 2024 

The 2024 TFSA limit is $7,000, the highest since the 2015 limit of $10,000. You could maximize this limit by…

Read more »

thinking
Stock Market

Is Brookfield Business Partners a Buy in 2024?

Down 20% from all-time highs, Brookfield Business Partners is a cheap TSX stock that should be on top of your…

Read more »

grow money, wealth build
Dividend Stocks

Here’s the Average RESP Balance and How to Boost it Big Time

The RESP can be an excellent tool for saving for a child's future. But is the average enough? And where…

Read more »

Two colleagues working on new global financial strategy plan using tablet and laptop.
Dividend Stocks

Best Stock to Buy Right Now: Manulife vs. CIBC?

These stock have enjoyed massive rallies in the past year. Are more gains on the way?

Read more »

investment research
Dividend Stocks

How to Use Your TFSA to Earn $12,000 Per Year in Tax-Free Income

The TFSA can act like a part-time job when invested properly, using your funds to turn your investments into the…

Read more »

edit Sale sign, value, discount
Dividend Stocks

1 Magnificent TSX Dividend Stock Down 60% to Buy and Hold Forever

Northwest Healthcare Properties is an overlooked TSX stock that's yielding more than 6% with solid fundamentals.

Read more »